Datar Srikant M.

Director · ICFI, TMUS

As of 2026-09-16, Datar Srikant M. has 7 Form 4 transactions on record across 2 companies — 4 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Pattern in the record: open-market sales filed in March in multiple years since 2025 — a recurring calendar cadence, more consistent with scheduled activity than a one-off decision.

Reconstructed holdings

Direct: $951KIndirect: $1.9M$2.9Mas of 2026-09-16
  • Direct $951K
  • Indirect $1.9M
TMUSindirect10,843 sh$1.9M
ICFIdirect5,998 sh$525K
TMUSdirect2,422 sh$427K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

TMUS · 5 trades
2026-06-16: Award / grant, 1,384 sh ($0)2026-03-10: Sale, 1,000 sh ($218K)2026-03-04: Sale, 3,291 sh ($728K)2025-06-06: Award / grant, 1,038 sh ($0)2025-03-05: Sale, 730 sh ($192K)
ICFI · 2 trades
2026-07-01: Award / grant, 2,277 sh ($0)2025-07-01: Award / grant, 1,720 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-03-10TMUSSale1,000 @ $218.25$218K−8.4% of holding10,843Form 4
2026-03-04TMUSSale3,291 @ $221.10$728K−76.0% of holding1,038Form 4
2025-03-05TMUSSale730 @ $263.00$192K−18.2% of holding3,291Form 4
4 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-07-01ICFIAward / grant2,2775,998Form 4
2026-06-16TMUSAward / grant1,3842,422Form 4
2025-07-01ICFIAward / grant1,7203,721Form 4
2025-06-06TMUSAward / grant1,0384,329Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.